Morten Søndergaard Jensen

Morten Søndergaard Jensen

Auto-generated profile, based on publicly available information

Morten Søndergaard Jensen

Department of Pediatrics, Randers Regional Hospital, Randers, Denmark

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 September 2006 in Human Reproduction
Verified
Journal Article
Open access
PDF file
CRC.H. Ramlau-Hansen
C.H. Ramlau-Hansen
ATA.M. Thulstrup
A.M. Thulstrup
AAA.S. Aggerholm
A.S. Aggerholm
MJM.S. Jensen
M.S. Jensen
Gunnar ToftGunnar Toft
Gunnar Toft
JBJ.P. Bonde
J.P. Bonde
BACKGROUND: Previous studies suggest a deleterious effect of cigarette smoking on semen quality, but their results have not been consistent. We studied the association between current smoking and semen characteristics and hormonal levels in a large group of healthy men. METHODS: From 1987 to 2004, seven separate occupational or environmental semen quality studies were co-ordinated by our department. A total of 2562 men participated, each providing semen and blood sample and answering a questionnaire about lifestyle and factors related to health. Appropriate semen and smoking data were available for 2542 men. RESULTS: Adjusting for study, age and other covariates, we observed an inverse dose–response relation between smoking and semen volume, total sperm count and percentage motile sperm. Heavy smokers had a 19% lower sperm concentration than non-smokers. We found a positive dose–response relationship between smoking and testosterone, LH and the LH/free testosterone ratios. CONCLUSION: Current smoking in adult life moderately impairs the semen quality. It is well known that semen quality is associated to fecundity. Therefore, it would be sensible to advise men to abstain from smoking to avoid decreased fecundity.

1 November 2010 in Epidemiology
Verified
Journal Article
Closed access
MJMorten Søndergaard Jensen
Morten Søndergaard Jensen
CRCristina Rebordosa
Cristina Rebordosa
ATAne Marie Thulstrup
Ane Marie Thulstrup
Gunnar ToftGunnar Toft
Gunnar Toft
Henrik Toft SørensenHenrik Toft Sørensen
Henrik Toft Sørensen
JOJørn Olsen
Jørn Olsen
Background: Cyclooxygenase (COX) inhibitors—acetaminophen, ibuprofen and acetylsalicylic acid—have endocrine-disruptive properties in the rainbow trout. In humans, aspirin blocks the androgen response to human chorionic gonadotropin (hCG), and, because hCG-stimulated androgen production in utero is crucial for normal testicular descent, exposure to COX inhibitors at vulnerable times during gestation may impair testicular descent. We examined whether prenatal exposure to acetaminophen, ibuprofen, and acetylsalicylic acid was associated with increased occurrence of cryptorchidism. Methods: Our study used data on 47,400 live-born singleton sons of mothers enrolled in the Danish National Birth Cohort during 1996-2002. Cryptorchidism was identified in 980 boys during childhood, of whom 565 underwent orchiopexy. The use of acetaminophen, ibuprofen, and acetylsalicylic acid during pregnancy was assessed in 3 computer-assisted telephone interviews and 1 self-administered questionnaire. We estimated adjusted hazard ratios (HRs) of cryptorchidism by Cox regression analysis. Results: Exposure to acetaminophen during both the first and second trimesters was associated with increased occurrence of cryptorchidism (HR = 1.33 [95% confidence interval = 1.00-1.77]). Exposure for more than 4 weeks within the postulated time-window of programming testicular descent (gestational weeks 8-14) was associated with a HR of 1.38 (1.05-1.83) for cryptorchidism. Exposure to ibuprofen and acetylsalicylic acid was not associated with cryptorchidism. Conclusion: Maternal intake of acetaminophen for more than 4 weeks during pregnancy, especially during the first and second trimesters, may moderately increase the occurrence of cryptorchidism.

1 June 2012 in Environmental Health Perspectives
Verified
Journal Article
Open access
MJMorten Søndergaard Jensen
Morten Søndergaard Jensen
BNBent Nørgaard-Pedersen
Bent Nørgaard-Pedersen
Gunnar ToftGunnar Toft
Gunnar Toft
DHDavid M. Hougaard
David M. Hougaard
JBJens Peter Bonde
Jens Peter Bonde
BJBo A.G. Jönsson
Bo A.G. Jönsson
A peer-reviewed open access journal published by the National Institute of Environmental Health Sciences

1 January 2015 in Epidemiology
Verified
Journal Article
Closed access
MJMorten Søndergaard Jensen
Morten Søndergaard Jensen
RARavinder Anand-Ivell
Ravinder Anand-Ivell
BNBent Nørgaard-Pedersen
Bent Nørgaard-Pedersen
BJBo A. G. Jönsson
Bo A. G. Jönsson
JBJens Peter Bonde
Jens Peter Bonde
Gunnar ToftGunnar Toft
Gunnar Toft
Background: Prenatal exposure to phthalates may pose a threat to human male reproduction. However, additional knowledge about the in vivo effect in humans is needed, and reported associations with genital abnormalities are inconclusive. We aimed to study prenatal di(2-ethylhexyl) phthalate (DEHP) and diisononyl phthalate (DiNP) exposure in relation to cryptorchidism, hypospadias, and human fetal Leydig cell function. Methods: We studied 270 cryptorchidism cases, 75 hypospadias cases, and 300 controls. Second-trimester amniotic fluid samples were available from a Danish pregnancy-screening biobank (n = 25,105) covering 1980–1996. We assayed metabolites of DEHP and DiNP (n = 645) and steroid hormones (n = 545) by mass spectrometry. We assayed insulin-like factor 3 by immunoassay (n = 475) and analyzed data using linear or logistic regression. Results: Mono(2-ethyl-5-carboxypentyl) phthalate (5cx-MEPP, DEHP metabolite) was not consistently associated with cryptorchidism or hypospadias. However, we observed an 18% higher (95% confidence interval [CI] = 5%–33%) testosterone level, and a 41% lower (−56% to −21%) insulin-like factor 3 level in the highest 5cx-MEPP tertile compared with the lowest. Mono(4-methyl-7-carboxyheptyl) phthalate (7cx-MMeHP, DiNP metabolite) showed elevated odds ratio point estimates for having cryptorchidism (odds ratio = 1.28 [95% CI = 0.80 to 2.01]) and hypospadias (1.69 [0.78 to 3.67]), but was not consistently associated with the steroid hormones or insulin-like factor 3. Conclusions: Data on the DEHP metabolite indicate possible interference with human male fetal gonadal function. Considering the DiNP metabolite, we cannot exclude (nor statistically confirm) an association with hypospadias and, less strongly, with cryptorchidism.

26 May 2005 in Human Reproduction
Verified
Journal Article
Open access
PDF file
MJM.S. Jensen
M.S. Jensen
LML.M. Mabeck
L.M. Mabeck
Gunnar ToftGunnar Toft
Gunnar Toft
ATA.M. Thulstrup
A.M. Thulstrup
JBJ.P. Bonde
J.P. Bonde
BACKGROUND: Recent findings have indicated that prenatal exposure to tobacco smoke may cause lower sperm concentration in ejaculates of adult men. To extend the research on this hypothesis we investigated the dose-dependency of the association, controlling for other prenatal exposures. METHODS: From 1987 to 1996, four separate occupational semen studies were conducted at three centres in Denmark. A total of 945 men provided semen and blood samples, and information on reproductive and lifestyle factors. In 2004, we collected data on the maternal smoking habits during pregnancy from 522 mothers of the participating men. RESULTS: Adjusting for study subgroup, abstinence time and other factors, we found statistically non-significant differences in mean sperm concentrations: 65.0×106/ml [95% confidence interval (CI) 51, 81] among sons of non-smokers; 59.1×106/ml (95% CI 46, 75) among sons of mothers who had smoked 1–10 cigarettes/day; and 57.7×106/ml (95% CI 40, 81) among those whose mothers had smoked >10 cigarettes/day. The former group had a higher odds ratio (OR) for oligozoospermia (sperm concentration ≤20×106/ml) of 1.5 (95% CI 0.9, 2.8), the latter group an OR of 2.6 (95% CI 1.2, 5.8). CONCLUSION: We observed a dose-dependent association between prenatal tobacco exposure, lower sperm concentration and higher risk of oligozoospermia.

27 March 2012 in American Journal of Epidemiology
Verified
Journal Article
Open access
PDF file
MJMorten Søndergaard Jensen
Morten Søndergaard Jensen
AWAllen J. Wilcox
Allen J. Wilcox
JOJørn Olsen
Jørn Olsen
JBJens Peter Bonde
Jens Peter Bonde
ATAne Marie Thulstrup
Ane Marie Thulstrup
THTine Brink Henriksen
Tine Brink Henriksen
Early delivery and low birth weight are strong predictors of the urogenital anomalies cryptorchidism (undescended testis) and hypospadias. Understanding these associations may lead to important etiologic clues. Therefore, the authors revisited the prevailing hypotheses regarding fetal growth restriction as a risk factor for urogenital anomalies. They studied a population of 934,538 Danish boys born alive between January 1, 1980, and December 31, 2008. Cryptorchidism and hypospadias were associated with low weight-for-gestational-age, an indicator of fetal growth restriction, and furthermore the authors observed strong interaction with early delivery. Low birth weight in a singleton compared with the mean birth weight of all singleton brothers in the family or in a twin compared with the male co-twin was associated with higher risk of urogenital anomalies, suggesting an effect of relative fetal growth restriction within families. Contrary to previous reports, newborns’ body dimensions assessed independently of birth weight were not associated with urogenital anomalies. The hypothesis that shared factors cause both fetal growth restriction and urogenital anomalies was supported by comparison of urogenital anomaly risks in singletons and twins and by patterns of cryptorchidism and hypospadias co-occurrence in individuals. These novel insights might also extend to other male reproductive conditions with prenatal etiology.